MAIA Biotechnology (MAIA) Assets (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Assets of $35.3 million for Q1 2026, up 197.71% year-over-year from $11.9 million in Q1 2025, and up 263.98% quarter-over-quarter from $9.7 million in Q4 2025.
MAIA Biotechnology (MAIA) Assets (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Assets for 6 consecutive years, with $35.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 197.71% year-over-year to $35.3 million; the TTM figure through Mar 2026 stood at $35.3 million (up 197.71% YoY), while the FY2025 annual figure was $9.7 million, down 4.44% from the prior year.
- Assets advanced to $35.3 million in Q1 2026 per MAIA's latest filing, from $9.7 million in the prior quarter.
- Across five years, Assets topped out at $35.3 million in Q1 2026 and bottomed at $7.0 million in Q3 2023.
- Historically, Assets has averaged $11.9 million across 5 years, with a median of $10.2 million in 2023.
- Annual changes were most pronounced in 2023 — Assets tumbled 52.64% — and 2026, when it soared 197.71%.
- MAIA Biotechnology's Assets stood at $12.0 million in 2022, then sank by 37.06% to $7.6 million in 2023, then surged by 34.21% to $10.2 million in 2024, then decreased by 4.44% to $9.7 million in 2025, then surged by 263.98% to $35.3 million in 2026.
- Business Quant data shows MAIA's Assets at $35.3 million in Q1 2026, $9.7 million in Q4 2025, and $11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | 28.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.24 Mn |
| Mar 31, 2026 | 35.32 Mn |
| Dec 31, 2025 | 9.70 Mn |
| Sep 30, 2025 | 11.78 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 11.86 Mn |
| Dec 31, 2024 | 10.16 Mn |
| Sep 30, 2024 | 9.24 Mn |
| Jun 30, 2024 | 12.02 Mn |
| Mar 31, 2024 | 8.72 Mn |
| Dec 31, 2023 | 7.57 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 10.27 Mn |
| Mar 31, 2023 | 9.07 Mn |
| Dec 31, 2022 | 12.02 Mn |
| Sep 30, 2022 | 14.78 Mn |
| Jun 30, 2022 | 9.76 Mn |
| Dec 31, 2021 | 11.33 Mn |